tazobactam has been researched along with Endocarditis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bremmer, DN; Kline, EG; Nicolau, DP; Shah, S; Shields, RK | 1 |
| Castillo Caparrós, A; Montijano Cabrera, AM | 1 |
2 other study(ies) available for tazobactam and Endocarditis
| Article | Year |
|---|---|
Ceftolozane/tazobactam for refractory P. aeruginosa endocarditis: A case report and pharmacokinetic analysis.
Topics: Anti-Bacterial Agents; Cephalosporins; Endocarditis; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
[Candida parapsilosis endocarditis after prolonged antibiotic therapy].
Topics: Candida; Candidiasis; Cardiac Tamponade; Cefazolin; Disease Susceptibility; Drug Therapy, Combination; Endocarditis; Fatal Outcome; Humans; Ischemia; Leg; Male; Middle Aged; Opportunistic Infections; Penicillanic Acid; Piperacillin; Postoperative Complications; Superinfection; Tazobactam | 2002 |